Respiratory Syncytial Virus, Human
"Respiratory Syncytial Virus, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.
MeSH Number(s)
B04.820.455.600.670.600.750.730
B04.909.777.455.600.670.600.750.730
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus, Human".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus, Human".
This graph shows the total number of publications written about "Respiratory Syncytial Virus, Human" by people in Harvard Catalyst Profiles by year, and whether "Respiratory Syncytial Virus, Human" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 2 | 2 | 4 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 4 | 1 | 5 |
| 2016 | 2 | 1 | 3 |
| 2017 | 4 | 0 | 4 |
| 2018 | 2 | 1 | 3 |
| 2019 | 5 | 1 | 6 |
| 2020 | 5 | 1 | 6 |
| 2021 | 8 | 3 | 11 |
| 2022 | 10 | 1 | 11 |
| 2023 | 14 | 2 | 16 |
| 2024 | 2 | 0 | 2 |
Below are the most recent publications written about "Respiratory Syncytial Virus, Human" by people in Profiles.
-
Clinical comparison of HMPV and RSV infections in hospitalised Malaysian children: A propensity score matched study. Clin Respir J. 2024 Mar; 18(3):e13747.
-
Bacterial small RNAs may mediate immune response differences seen in respiratory syncytial virus versus rhinovirus bronchiolitis. Front Immunol. 2024; 15:1330991.
-
Impact of SARS-CoV-2 Prevention Measures on Non-SARS-CoV-2 Hospital-Onset Respiratory Viral Infections: An Incidence Trend Analysis From 2015-2023. Clin Infect Dis. 2023 12 15; 77(12):1696-1699.
-
Implications of Food and Drug Administration Approval of Respiratory Syncytial Virus Prophylactic Medication. Pediatr Rev. 2023 12 01; 44(12):723-724.
-
Respiratory Virus-Specific Nasopharyngeal Lipidome Signatures and Severity in Infants With Bronchiolitis: A Prospective Multicenter Study. J Infect Dis. 2023 11 11; 228(10):1410-1420.
-
Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine. J Virol. 2023 Nov 30; 97(11):e0077123.
-
Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients. J Immunol. 2023 10 15; 211(8):1224-1231.
-
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023 Oct 13; 72(41):1115-1122.
-
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged =60 Years - IVY Network, 20 U.S. States, February 2022-May 2023. MMWR Morb Mortal Wkly Rep. 2023 Oct 06; 72(40):1083-1088.
-
Association of respiratory virus types with clinical features in bronchiolitis: Implications for virus testing strategies. A systematic review and meta-analysis. Paediatr Respir Rev. 2024 Mar; 49:34-42.